HCM
Hutchinson Capital Management Portfolio holdings
AUM
$548M
1-Year Return
12.58%
This Quarter Return
+1.64%
1 Year Return
+12.58%
3 Year Return
+50.43%
5 Year Return
+107.91%
10 Year Return
+193.52%
AUM
$319M
AUM Growth
-$35.3M
(-10%)
Cap. Flow
-$40M
Cap. Flow
% of AUM
-12.54%
Top 10 Holdings %
Top 10 Hldgs %
57.71%
Holding
63
New
–
Increased
10
Reduced
26
Closed
7
Top Buys
| 1 |
NOV
NOV
|
$2.88M |
| 2 |
Emerson Electric
EMR
|
$637K |
| 3 |
Unilever
UL
|
$574K |
| 4 |
CB
CHUBB CORPORATION
CB
|
$519K |
| 5 |
Exxon Mobil
XOM
|
$330K |
Top Sells
| 1 |
American Eagle Outfitters
AEO
|
$11.5M |
| 2 |
CVS Health
CVS
|
$8.61M |
| 3 |
Arcos Dorados Holdings
ARCO
|
$6.12M |
| 4 |
Microsoft
MSFT
|
$5.07M |
| 5 |
Johnson Controls International
JCI
|
$4.48M |
Sector Composition
| 1 | Financials | 29.48% |
| 2 | Consumer Discretionary | 18.82% |
| 3 | Industrials | 12.82% |
| 4 | Healthcare | 11.61% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $2.25M | 0.7% |
68,148
+316
| +0.5% | +$10.4K |
|
|
COL
27
DELISTED
Rockwell Collins
COL
| $1.91M | 0.6% |
19,744
| – | – |
|
28
Procter & Gamble
PG
$375B
| $1.66M | 0.52% |
20,213
-75
| -0.4% | -$6.15K |
|
|
ESRX
29
DELISTED
Express Scripts Holding Company
ESRX
| $1.2M | 0.38% |
13,842
+2,030
| +17% | +$176K |
|
30
Johnson & Johnson
JNJ
$430B
| $1.19M | 0.37% |
11,821
-50
| -0.4% | -$5.03K |
|
31
PepsiCo
PEP
$200B
| $1.14M | 0.36% |
11,933
-50
| -0.4% | -$4.78K |
|
32
Clorox
CLX
$15.5B
| $892K | 0.28% |
8,080
| – | – |
|
33
GE Aerospace
GE
$296B
| $854K | 0.27% |
7,188
| – | – |
|
34
Target
TGT
$42.3B
| $785K | 0.25% |
9,572
| – | – |
|
35
RTX Corp
RTX
$211B
| $771K | 0.24% |
10,451
| – | – |
|
|
36
American Eagle Outfitters
AEO
$3.26B
| $745K | 0.23% |
43,620
-671,749
| -94% | -$11.5M |
|
37
IBM
IBM
$232B
| $661K | 0.21% |
4,307
-6
| -0.1% | -$921 |
|
|
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $579K | 0.18% |
9,710
| – | – |
|
39
Sempra
SRE
$52.9B
| $576K | 0.18% |
10,560
| – | – |
|
40
Novartis
NVS
$251B
| $568K | 0.18% |
6,427
| – | – |
|
41
Genuine Parts
GPC
$19.4B
| $537K | 0.17% |
5,760
| – | – |
|
42
3M
MMM
$82.7B
| $518K | 0.16% |
3,755
| – | – |
|
43
Bristol-Myers Squibb
BMY
$96B
| $517K | 0.16% |
8,017
-110
| -1% | -$7.09K |
|
44
Coca-Cola
KO
$292B
| $410K | 0.13% |
10,118
| – | – |
|
45
Apple
AAPL
$3.56T
| $324K | 0.1% |
10,412
-1,216
| -10% | -$37.8K |
|
46
McKesson
MCK
$85.5B
| $316K | 0.1% |
1,395
| – | – |
|
47
Marsh & McLennan
MMC
$100B
| $306K | 0.1% |
5,462
-263
| -5% | -$14.7K |
|
|
MON
48
DELISTED
Monsanto Co
MON
| $284K | 0.09% |
2,523
| – | – |
|
49
Berkshire Hathaway Class B
BRK.B
$1.08T
| $277K | 0.09% |
1,917
-50
| -3% | -$7.23K |
|
50
Abbott
ABT
$231B
| $268K | 0.08% |
5,788
| – | – |
|